A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases
- PMID: 7718169
- DOI: 10.3109/02688699409101186
A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases
Abstract
Radiosurgery has been advocated as a salvage treatment for relapsed patients with brain metastases. This report describes a phase I/II study of salvage radiosurgery for patients previously treated with whole brain irradiation. The study was opened in March 1989 and the last patient was treated in July 1992. All patients have been followed to recurrence at the radiosurgically treated site or to death. Twenty progressing metastases in 12 patients were treated using 14 radiosurgical procedures. The radiation dose was always 25 Gy with the 90% isodose volume encompassing all enhancing tumour. Nineteen metastases were evaluable at +4 weeks. There were no instances of progressive disease; there were three complete responses, six partial responses, and 10 metastases remained unchanged. Median survival from the date of radiosurgery was 6 months. Nine of 12 patients eventually failed at the radiosurgically treated site (two remain alive). Radiosurgery at the time of relapse provides temporary control of recurrent brain metastases with acceptable toxicity.
Similar articles
-
Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.Cancer J. 2000 Mar-Apr;6(2):88-92. Cancer J. 2000. PMID: 11069225
-
Radiation dose and incidence of new metastasis in the anterior temporal lobe structures of radiosurgically treated patients.J Neurosurg. 2010 Jan;112(1):122-9. doi: 10.3171/2009.4.JNS09249. J Neurosurg. 2010. PMID: 19499979
-
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.J Neurosurg. 2017 Jul;127(1):148-156. doi: 10.3171/2016.5.JNS153051. Epub 2016 Aug 5. J Neurosurg. 2017. PMID: 27494815
-
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46. doi: 10.1016/j.ijrobp.2005.05.023. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111570 Review.
-
Radiosurgery for the treatment of brain metastases in renal cell carcinoma.Anticancer Res. 1999 Mar-Apr;19(2C):1611-7. Anticancer Res. 1999. PMID: 10365156 Review.
Cited by
-
The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.J Neurooncol. 2013 Jul;113(3):459-65. doi: 10.1007/s11060-013-1138-y. Epub 2013 May 10. J Neurooncol. 2013. PMID: 23661101 Clinical Trial.
-
Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.J Neurooncol. 2011 Sep;104(3):817-24. doi: 10.1007/s11060-011-0553-1. Epub 2011 Mar 23. J Neurooncol. 2011. PMID: 21431468
-
The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.J Neurooncol. 2010 Jan;96(1):85-96. doi: 10.1007/s11060-009-0055-6. Epub 2009 Dec 3. J Neurooncol. 2010. PMID: 19957016 Free PMC article.
-
Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis.Brain Tumor Res Treat. 2020 Oct;8(2):93-102. doi: 10.14791/btrt.2020.8.e11. Epub 2020 Jul 9. Brain Tumor Res Treat. 2020. PMID: 32648383 Free PMC article.
-
Chemosensitized radiosurgery for recurrent brain metastases.J Neurooncol. 2012 Nov;110(2):265-70. doi: 10.1007/s11060-012-0965-6. Epub 2012 Aug 22. J Neurooncol. 2012. PMID: 22910852 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical